Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Last Name

profileCorrine K. Welt, M.D.

TitleResearch Associate in Medicine
InstitutionMassachusetts General Hospital
AddressMassachusetts General Hospital
Endocrine, Bhx 501
55 Fruit St
Boston MA 02114
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse completed student projects
The effect of recombinant human prolactin on milk composition
Summer, 06/18/07 - 08/10/07
The Effect of Prolactin on the Reproductive Axis PASTEUR
Summer, 07/01/00 - 08/30/00
The Role of Prolactin in Female Reproduction
Summer, 06/24/02 - 08/16/02
Natural History of Polycystic Ovary Morphology: Conversion to Normal Ovarian Morphology
Summer, 06/27/05 - 08/19/05

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01HD065029     (WELT, CORRINE K)Sep 15, 2010 - May 31, 2015
The Genetics of Polycystic Ovary Syndrom
Role: Principal Investigator

R01FD003014     (WELT, CORRINE K)Sep 30, 2005 - Jun 30, 2009
Phase 2 Trial of Recombinant Human Prolactin for Lactation Insufficiency
Role: Principal Investigator

M01RR002635     (GOTTLIEB, GARY L)Dec 1, 1984 - Mar 31, 2010
General Clinical Research Center
Role: Co-Principal Investigator

M01RR001066     (SLAVIN, PETER L)Feb 1, 1978 - May 31, 2008
General Clinical Research Center
Role: Co-Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Styrkarsdottir U, Helgason H, Sigurdsson A, Norddahl GL, Agustsdottir AB, Reynard LN, Villalvilla A, Halldorsson GH, Jonasdottir A, Magnusdottir A, Oddson A, Sulem G, Zink F, Sveinbjornsson G, Helgason A, Johannsdottir HS, Helgadottir A, Stefansson H, Gretarsdottir S, Rafnar T, Almdahl IS, Brækhus A, Fladby T, Selbæk G, Hosseinpanah F, Azizi F, Koh JM, Tang NLS, Daneshpour MS, Mayordomo JI, Welt C, Braund PS, Samani NJ, Kiemeney LA, Lohmander LS, Christiansen C, Andreassen OA, Magnusson O, Masson G, Kong A, Jonsdottir I, Gudbjartsson D, Sulem P, Jonsson H, Loughlin J, Ingvarsson T, Thorsteinsdottir U, Stefansson K. Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis. Nat Genet. 2017 May; 49(5):801-805. PMID: 28319091.
    View in: PubMed
  2. Pau CT, Mosbruger T, Saxena R, Welt CK. Phenotype and Tissue Expression as a Function of Genetic Risk in Polycystic Ovary Syndrome. PLoS One. 2017; 12(1):e0168870. PMID: 28068351.
    View in: PubMed
  3. Pau CT, Cheang KI, Modi BP, Kasippillai T, Keefe CC, Shulleeta M, Evans WS, Pal L, Strauss JF, Nestler JE, Welt CK. The role of variants regulating metformin transport and action in women with polycystic ovary syndrome. Pharmacogenomics. 2016 Oct 28. PMID: 27790932.
    View in: PubMed
  4. Bjonnes AC, Saxena R, Welt CK. Relationship between polycystic ovary syndrome and ancestry in European Americans. Fertil Steril. 2016 Dec; 106(7):1772-1777. PMID: 27666562.
    View in: PubMed
  5. Ravindra VM, Raheja A, Corn H, Driscoll M, Welt C, Simmons DL, Couldwell WT. Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report. J Neurosurg. 2017 May; 126(5):1725-1730. PMID: 27518527.
    View in: PubMed
  6. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, Azziz R, Zhang Y, James RG, Olivier M, Kissebah AH, Stener-Victorin E, Legro RS, Dunaif A. Corrigendum: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2016 Feb 12; 7:10762. PMID: 26867975; PMCID: PMC4754347.
  7. Castro V, Shen Y, Yu S, Finan S, Pau CT, Gainer V, Keefe CC, Savova G, Murphy SN, Cai T, Welt CK. Identification of subjects with polycystic ovary syndrome using electronic health records. Reprod Biol Endocrinol. 2015 Oct 29; 13:116. PMID: 26510685; PMCID: PMC4625743.
  8. Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, Lawlor DA, Laval G, Mathieson I, McCardle WL, Louwers Y, Meun C, Ring S, Scott RA, Sulem P, Uitterlinden AG, Wareham NJ, Thorsteinsdottir U, Welt C, Stefansson K, Laven JS, Ong KK, Perry JR. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015 Sep 29; 6:8464. PMID: 26416764; PMCID: PMC4598835.
  9. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, Lindgren CM, Welt CK, Diamanti-Kandarakis E, Panidis D, Goodarzi MO, Azziz R, Zhang Y, James RG, Olivier M, Kissebah AH, Stener-Victorin E, Legro RS, Dunaif A. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015 Aug 18; 6:7502. PMID: 26284813; PMCID: PMC4557132.
  10. Shaw ND, Srouji SS, Welt CK, Cox KH, Fox JH, Adams JA, Sluss PM, Hall JE. Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women. J Clin Endocrinol Metab. 2015 Sep; 100(9):3539-47. PMID: 26126208; PMCID: PMC4570155 [Available on 09/01/16].
  11. Saxena R, Bjonnes AC, Georgopoulos NA, Koika V, Panidis D, Welt CK. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume. Hum Reprod. 2015 Jul; 30(7):1697-703. PMID: 25994816; PMCID: PMC4472323 [Available on 07/01/16].
  12. Saxena R, Georgopoulos NA, Braaten TJ, Bjonnes AC, Koika V, Panidis D, Welt CK. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod. 2015 Jun; 30(6):1454-9. PMID: 25904635; PMCID: PMC4498224 [Available on 06/01/16].
  13. Welt CK, Duran JM. Genetics of polycystic ovary syndrome. Semin Reprod Med. 2014 May; 32(3):177-82. PMID: 24715512; PMCID: PMC4066994.
  14. Keefe CC, Goldman MM, Zhang K, Clarke N, Reitz RE, Welt CK. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PLoS One. 2014; 9(4):e93805. PMID: 24713888; PMCID: PMC3979722.
  15. Pau CT, Keefe C, Duran J, Welt CK. Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. J Clin Endocrinol Metab. 2014 May; 99(5):1870-8. PMID: 24606093; PMCID: PMC4010712.
  16. Hoeger KM, Legro RS, Welt CK. A patient's guide: polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 2014 Jan; 99(1):35A-36A. PMID: 24384023.
    View in: PubMed
  17. Shaw ND, Srouji SS, Welt CK, Cox KH, Fox JH, Adams JM, Sluss PM, Hall JE. Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women. J Clin Endocrinol Metab. 2014 Apr; 99(4):1384-92. PMID: 24285681; PMCID: PMC3973772.
  18. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 Dec; 98(12):4565-92. PMID: 24151290.
    View in: PubMed
  19. Domecq JP, Prutsky G, Mullan RJ, Sundaresh V, Wang AT, Erwin PJ, Welt C, Ehrmann D, Montori VM, Murad MH. Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013 Dec; 98(12):4646-54. PMID: 24092830.
    View in: PubMed
  20. Welt CK, Carmina E. Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013 Dec; 98(12):4629-38. PMID: 24064685; PMCID: PMC3849665.
  21. Georgopoulos NA, Karagiannidou E, Koika V, Roupas ND, Armeni A, Marioli D, Papadakis E, Welt CK, Panidis D. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels. J Clin Endocrinol Metab. 2013 Nov; 98(11):E1866-70. PMID: 23969185.
    View in: PubMed
  22. Iwama S, Welt CK, Romero CJ, Radovick S, Caturegli P. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab. 2013 Oct; 98(10):3920-5. PMID: 23940128; PMCID: PMC3790613.
  23. Kasippillai T, MacArthur DG, Kirby A, Thomas B, Lambalk CB, Daly MJ, Welt CK. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab. 2013 Sep; 98(9):E1534-9. PMID: 23902945.
    View in: PubMed
  24. van Erven B, Gubbels CS, van Golde RJ, Dunselman GA, Derhaag JG, de Wert G, Geraedts JP, Bosch AM, Treacy EP, Welt CK, Berry GT, Rubio-Gozalbo ME. Fertility preservation in female classic galactosemia patients. Orphanet J Rare Dis. 2013 Jul 16; 8:107. PMID: 23866841; PMCID: PMC3718676.
  25. Pau CT, Keefe CC, Welt CK. Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. Gynecol Endocrinol. 2013 Jun; 29(6):551-5. PMID: 23656383; PMCID: PMC4077900.
  26. Pau C, Saxena R, Welt CK. Evaluating reported candidate gene associations with polycystic ovary syndrome. Fertil Steril. 2013 May; 99(6):1774-8. PMID: 23375202; PMCID: PMC3722586.
  27. Abel BS, Shaw ND, Brown JM, Adams JM, Alati T, Martin KA, Pitteloud N, Seminara SB, Plummer L, Pignatelli D, Crowley WF, Welt CK, Hall JE. Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013 Feb; 98(2):E206-16. PMID: 23341491; PMCID: PMC3565114.
  28. Gubbels CS, Welt CK, Dumoulin JC, Robben SG, Gordon CM, Dunselman GA, Rubio-Gozalbo ME, Berry GT. The male reproductive system in classic galactosemia: cryptorchidism and low semen volume. J Inherit Metab Dis. 2013 Sep; 36(5):779-86. PMID: 23053469.
    View in: PubMed
  29. Lie Fong S, Visser JA, Welt CK, de Rijke YB, Eijkemans MJ, Broekmans FJ, Roes EM, Peters WH, Hokken-Koelega AC, Fauser BC, Themmen AP, de Jong FH, Schipper I, Laven JS. Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012 Dec; 97(12):4650-5. PMID: 22993032; PMCID: PMC3683801.
  30. Welt CK, Styrkarsdottir U, Ehrmann DA, Thorleifsson G, Arason G, Gudmundsson JA, Ober C, Rosenfield RL, Saxena R, Thorsteinsdottir U, Crowley WF, Stefansson K. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012 Jul; 97(7):E1342-7. PMID: 22547425; PMCID: PMC3387396.
  31. Batey LA, Welt CK, Rohr F, Wessel A, Anastasoaie V, Feldman HA, Guo CY, Rubio-Gozalbo E, Berry G, Gordon CM. Skeletal health in adult patients with classic galactosemia. Osteoporos Int. 2013 Feb; 24(2):501-9. PMID: 22525982.
    View in: PubMed
  32. Saxena R, Welt CK. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol. 2013 Jun; 50(3):451-7. PMID: 22389004; PMCID: PMC3679224.
  33. Carroll J, Saxena R, Welt CK. Environmental and genetic factors influence age at menarche in women with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2012; 25(5-6):459-66. PMID: 22876539; PMCID: PMC3597236.
  34. Chang MC, DeCaro JJ, Zheng M, Gearing M, Shubeck L, Sherman SL, Welt CK. Ovarian histopathological and ubiquitin-immunophenotypic features in fragile X-associated primary ovarian insufficiency: a study of five cases and selected controls. Histopathology. 2011 Nov; 59(5):1018-23. PMID: 22007616; PMCID: PMC3220768.
  35. Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011 Jul; 29(4):299-307. PMID: 21969264.
    View in: PubMed
  36. Waisbren SE, Potter NL, Gordon CM, Green RC, Greenstein P, Gubbels CS, Rubio-Gozalbo E, Schomer D, Welt C, Anastasoaie V, D'Anna K, Gentile J, Guo CY, Hecht L, Jackson R, Jansma BM, Li Y, Lip V, Miller DT, Murray M, Power L, Quinn N, Rohr F, Shen Y, Skinder-Meredith A, Timmers I, Tunick R, Wessel A, Wu BL, Levy H, Elsas L, Berry GT. The adult galactosemic phenotype. J Inherit Metab Dis. 2012 Mar; 35(2):279-86. PMID: 21779791; PMCID: PMC3641771.
  37. Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, Ginsburg E, Thornton KL, Welt CK. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2011 Aug; 26(8):2077-83. PMID: 21646280.
    View in: PubMed
  38. Powe CE, Puopolo KM, Newburg DS, Lönnerdal B, Chen C, Allen M, Merewood A, Worden S, Welt CK. Effects of recombinant human prolactin on breast milk composition. Pediatrics. 2011 Feb; 127(2):e359-66. PMID: 21262884; PMCID: PMC3387861.
  39. Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, Avbelj M, Dhruvakumar S, Plummer L, Hughes VA, Seminara SB, Boepple PA, Sidis Y, Crowley WF, Martin KA, Hall JE, Pitteloud N. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011 Jan 20; 364(3):215-25. PMID: 21247312; PMCID: PMC3045842.
  40. Shaw ND, Seminara SB, Welt CK, Au MG, Plummer L, Hughes VA, Dwyer AA, Martin KA, Quinton R, Mericq V, Merino PM, Gusella JF, Crowley WF, Pitteloud N, Hall JE. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011 Mar; 96(3):E566-76. PMID: 21209029; PMCID: PMC3047229.
  41. Powe CE, Allen M, Puopolo KM, Merewood A, Worden S, Johnson LC, Fleischman A, Welt CK. Recombinant human prolactin for the treatment of lactation insufficiency. Clin Endocrinol (Oxf). 2010 Nov; 73(5):645-53. PMID: 20718766.
    View in: PubMed
  42. Karimov CB, Cronister A, Srouji S, Petrozza J, Racowsky C, Ginsburg E, Santolaya J, Welt C. FMR1 Repeat Length in Infertile Women with Primary Ovarian Insufficiency. 2010 ACMG Annual Clinical Genetics Meeting. 2010.
  43. Alsamarai S, Adams JM, Murphy MK, Post MD, Hayden DL, Hall JE, Welt CK. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab. 2009 Dec; 94(12):4961-70. PMID: 19846740; PMCID: PMC2795657.
  44. Powe CE, Welt CK. The Effect of Recombinant Human Prolactin on Breast Milk Composition. Proceedings of the 90th Annual Meeting of the Endocrine Society. 2008.
  45. Welt CK. Autoimmune oophoritis in the adolescent. Ann N Y Acad Sci. 2008; 1135:118-22. PMID: 18574216.
    View in: PubMed
  46. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008 Apr; 68(4):499-509. PMID: 17970776.
    View in: PubMed
  47. Gallardo TD, John GB, Bradshaw K, Welt C, Reijo-Pera R, Vogt PH, Touraine P, Bione S, Toniolo D, Nelson LM, Zinn AR, Castrillon DH. Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea. Hum Reprod. 2008 Jan; 23(1):216-21. PMID: 17959613; PMCID: PMC2579771.
  48. Page-Wilson G, Smith PC, Welt CK. Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent. Int Breastfeed J. 2007 Jul 24; 2:10. PMID: 17650319; PMCID: PMC1950489.
  49. Welt CK. Will leptin become the treatment of choice for functional hypothalamic amenorrhea? Nat Clin Pract Endocrinol Metab. 2007 Aug; 3(8):556-7. PMID: 17593916.
    View in: PubMed
  50. Welt CK. Hypothalamic-pituitary axis. Rose BD, editor. UpToDate. 2007.
  51. Welt CK. Pathogenesis and causes of spontaneous premature ovarian failure. Rose BD, editor. UpToDate. 2007.
  52. Gudmundsson J, Arason G, Adams JM, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Welt CK. Evidence for Increased Metabolic Dysfunction in Mothers and Fathers of Women with Polycystic Ovary Syndrome with No Increase in Myocardial Infarction. Proceedings of the 89th Annual Meeting of the Endocrine Society. 2007.
  53. Welt CK. The normal menstrual cycle. Rose BD, editor. UpToDate. 2007.
  54. Welt CK. Evaluation of the menstrual cycle and timing of ovulation. Rose BD, editor. UpToDate. 2007.
  55. Welt CK, Barbieri RL. Etiology, diagnosis, and treatment of primary amenorrhea. Rose BD, editor. UpToDate. 2007.
  56. Welt CK, Barbieri RL. Etiology, diagnosis, and treatment of secondary amenorrhea. Rose BD, editor. UpToDate. 2007.
  57. Welt CK. Physiology of gonadotropin-releasing hormone. Rose BD, editor. UpToDate. 2007.
  58. Welt CK. Ovarian development and failure (menopause) in normal women. Rose BD, editor. UpToDate. 2007.
  59. Gill S, Welt CK, Yialamas MA, Hall JE. Female Reproduction. Davies TF, editor. A Case-Based Textbook of Clinical Endocrinology. 2007.
  60. Welt CK, Shapiro C. Ovarian failure due to anticancer drugs and radiation. Rose BD, editor. UpToDate. 2007.
  61. Welt CK. Patient information: Menstrual cycle disorders. 2007.
  62. Cerrato F, Shagoury J, Kralickova M, Dwyer A, Falardeau J, Ozata M, Van Vliet G, Bouloux P, Hall JE, Hayes FJ, Pitteloud N, Martin KA, Welt C, Seminara SB. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur J Endocrinol. 2006 Nov; 155 Suppl 1:S3-S10. PMID: 17074994.
    View in: PubMed
  63. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertil Steril. 2007 Mar; 87(3):456-65. PMID: 17074338.
    View in: PubMed
  64. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab. 2006 Dec; 91(12):4842-8. PMID: 17003085.
    View in: PubMed
  65. Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdóttir H, Gudlaugsdóttir G, Ingadóttir G, Crowley WF. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab. 2006 Nov; 91(11):4361-8. PMID: 16940441.
    View in: PubMed
  66. Murphy MK, Hall JE, Adams JM, Lee H, Welt CK. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Oct; 91(10):3878-84. PMID: 16882750.
    View in: PubMed
  67. Welt CK, Jimenez Y, Sluss PM, Smith PC, Hall JE. Control of estradiol secretion in reproductive ageing. Hum Reprod. 2006 Aug; 21(8):2189-93. PMID: 16684841.
    View in: PubMed
  68. Welt, CK. Androgen Excess Guidelines are Too Restrictive. J Clin Endocrinol Metab. 2006.
  69. Page-Wilson G, Smith PC, Welt CK. Prolactin suppresses GnRH but not TSH secretion. Horm Res. 2006; 65(1):31-8. PMID: 16357488.
    View in: PubMed
  70. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM, Schneyer AL. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab. 2005 Oct; 90(10):5582-7. PMID: 16030174.
    View in: PubMed
  71. Welt CK, Falorni A, Taylor AE, Martin KA, Hall JE. Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels. J Clin Endocrinol Metab. 2005 May; 90(5):3069-76. PMID: 15705922.
    View in: PubMed
  72. Welt, CK. Leptin & Hypothalamic Amenorrhea. 2005.
  73. Welt, CK. . Premature Ovarian Failure: Diagnosis and Longterm Management. 2005.
  74. Welt CK, Hall JE, Adams JM, Taylor AE. Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure. J Clin Endocrinol Metab. 2005 Feb; 90(2):826-30. PMID: 15562017.
    View in: PubMed
  75. Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM, Karalis A, Mantzoros CS. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med. 2004 Sep 02; 351(10):987-97. PMID: 15342807.
    View in: PubMed
  76. Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab. 2004 Sep; 89(9):4569-74. PMID: 15356064.
    View in: PubMed
  77. Welt CK. Regulation and function of inhibins in the normal menstrual cycle. Semin Reprod Med. 2004 Aug; 22(3):187-93. PMID: 15319821.
    View in: PubMed
  78. Welt CK. Are there practical benefits from measuring the inhibins?. Filicori M, editor. Updates in Infertility Treatment 2004. 2004; 251-263.
  79. Welt CK, Schneyer AL, Heist K, Mantzoros CS. Leptin and soluble leptin receptor in follicular fluid. J Assist Reprod Genet. 2003 Dec; 20(12):495-501. PMID: 15035548; PMCID: PMC3455309.
  80. Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE. Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab. 2003 Apr; 88(4):1766-71. PMID: 12679471.
    View in: PubMed
  81. Welt CK. Insulin Resistance in Polycystic Ovary Syndrome. Endocrinology Rounds. 2003; 7:1-8.
  82. Welt CK, Taylor AE, Martin KA, Hall JE. Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone. J Clin Endocrinol Metab. 2002 Dec; 87(12):5559-65. PMID: 12466353.
    View in: PubMed
  83. Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood). 2002 Oct; 227(9):724-52. PMID: 12324653.
    View in: PubMed
  84. Welt CK. The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol. 2002 Jun; 14(3):317-23. PMID: 12032389.
    View in: PubMed
  85. Welt, CK. Hypogonadotropic and Hypergonadotropic Amenorrhea. 2002.
  86. Schneyer A, Welt C. Reproductive endocrinology of inhibin, activin, and follistatin. Endocrinology Rounds. 2002; 1:1-6.
  87. Welt CK. Menstrual Disorders. 2002.
  88. Welt C, Sidis Y, Keutman H, Schneyer A. Activins, inhibins and follistatins. From endocrinology to signaling: a paradigm for the new millennium. Proc Exp Biol Med. 2002; 227:724-752.
  89. Welt, CK. Menstrual Cycle Evaluation. 2002.
  90. Fujiwara T, Sidis Y, Welt C, Lambert-Messerlian G, Fox J, Taylor A, Schneyer A. Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles. J Clin Endocrinol Metab. 2001 Sep; 86(9):4206-15. PMID: 11549651.
    View in: PubMed
  91. Welt CK, Smith ZA, Pauler DK, Hall JE. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development. J Clin Endocrinol Metab. 2001 Jun; 86(6):2531-7. PMID: 11397851.
    View in: PubMed
  92. Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001 Jun; 86(6):2428-36. PMID: 11397835.
    View in: PubMed
  93. Welt CK, Schneyer AL. Differential regulation of inhibin B and inhibin a by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles. J Clin Endocrinol Metab. 2001 Jan; 86(1):330-6. PMID: 11232020.
    View in: PubMed
  94. Schneyer AL, Fujiwara T, Fox J, Welt CK, Adams J, Messerlian GM, Taylor AE. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab. 2000 Sep; 85(9):3319-30. PMID: 10999828.
    View in: PubMed
  95. Taylor AE, Hall JE, Adams JM, Martin KA, Welt CK, Crowley Jr WF. The physiology of the human mid-cycle gonadotropin surge. Adashi E, editor. Ovulation. 2000; 79-98.
  96. Hall JE, Welt CK. Inhibin and female reproduction. Filicori M, editor. Endocrine Basis of Reproductive Function. 2000; 151-167.
  97. Welt C, Hall JE. Abnormal ovulation: Basic evaluation and hypothalamic and pituitary disorders. Spratt D, Santoro N, editors. Endocrinology of Fertility and the Reproductive System: Practical Aspects. 2000.
  98. Welt CK, Adams JM, Sluss PM, Hall JE. Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development. J Clin Endocrinol Metab. 1999 Jun; 84(6):2163-9. PMID: 10372726.
    View in: PubMed
  99. Hall JE, Welt CK, Cramer DW. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod. 1999 Feb; 14(2):409-15. PMID: 10099988.
    View in: PubMed
  100. Hayes FJ, Welt CK, Martin KA, Crowley Jr WF. Gonadotropin-releasing hormone deficiency: differential diagnosis and treatment. Endocrinologist. 1999; 9:36-44.
  101. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab. 1999 Jan; 84(1):105-11. PMID: 9920069.
    View in: PubMed
  102. Welt CK, Crowley WF. Activin: an endocrine or paracrine agent? Eur J Endocrinol. 1998 Nov; 139(5):469-71. PMID: 9849807.
    View in: PubMed
  103. Welt CK, Kinsley BT, Simonson DC. Recurrent hypoglycemia does not impair the cortisol response to adrenocorticotropin infusion in healthy humans. Metabolism. 1998 Oct; 47(10):1252-7. PMID: 9781630.
    View in: PubMed
  104. Martin KA, Welt CK, Taylor AE, Smith JA, Crowley WF, Hall JE. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model. Neuroendocrinology. 1998 Jun; 67(6):363-9. PMID: 9662715.
    View in: PubMed
  105. Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol. 1998 Apr; 69(1):23-31. PMID: 9570994.
    View in: PubMed
  106. Di Simone N, Hall HA, Welt C, Schneyer AL. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells. Endocrinology. 1998 Mar; 139(3):1147-55. PMID: 9492049.
    View in: PubMed
  107. Di Simone N, Hall HA, Welt C, Schneyer AL. Activin Regulates ßA-Subunit and Activin Receptor Messenger Ribonucleic Acid and Cellular Proliferation in Activin-Responsive Testicular Tumor Cells. Endocrinology. 1998 Mar 01; 139(3):1147-1155. PMID: 28200500.
    View in: PubMed
  108. Welt CK, Lambert-Messerlian G, Zheng W, Crowley WF, Schneyer AL. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J Clin Endocrinol Metab. 1997 Nov; 82(11):3720-7. PMID: 9360531.
    View in: PubMed
  109. Welt CK, Martin KA, Taylor AE, Lambert-Messerlian GM, Crowley WF, Smith JA, Schoenfeld DA, Hall JE. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab. 1997 Aug; 82(8):2645-52. PMID: 9253348.
    View in: PubMed
  110. Welt C, Hall JE. Gonadotropin deficiency: differential diagnosis and treatment. Conn PM, Weirman MS, editors. Pituitary Disease: Diagnosis and Treatment. 1997; 221-246.
  111. Welt C, Abbs JH. Musculotopic organization of the facial motor nucleus in Macaca fascicularis: a morphometric and retrograde tracing study with cholera toxin B-HRP. J Comp Neurol. 1990 Jan 22; 291(4):621-36. PMID: 2329193.
    View in: PubMed
  112. Richey B, Cayley DS, Mossing MC, Kolka (Welt) C, Anderson CF, Farrar TC, Record Jr MT. Variability of the intracellular ionic environment of E. Coli: Differences between in vitro and in vivo effects of ion concentrations on protein-DNA interactions and gene expression. J Biol Chem. 1987; 262:7157-7164.
  113. Forbes DJ, Welt C. Neurogenesis in the trigeminal ganglion of the albino rat: a quantitative autoradiographic study. J Comp Neurol. 1981 Jun 10; 199(1):133-47. PMID: 6973574.
    View in: PubMed
  114. Wong-Riley MT, Welt C. Histochemical changes in cytochrome oxidase of cortical barrels after vibrissal removal in neonatal and adult mice. Proc Natl Acad Sci U S A. 1980 Apr; 77(4):2333-7. PMID: 6246540; PMCID: PMC348709.
  115. Carlson M, Welt C. Somatic sensory cortex (SmI) of the prosimian primate Galago crassicaudatus: organization of mechanoreceptive input from the hand in relation to cytoarchitecture. J Comp Neurol. 1980 Jan 15; 189(2):249-71. PMID: 7364964.
    View in: PubMed
  116. Welt C, Steindler DA. Somatosensory cortical barrels and thalamic barreloids in reeler mutant mice. Neuroscience. 1977; 2(5):755-66. PMID: 593554.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at For faculty personal and demographic information, contact HMS Office for Faculty Affairs at
Welt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
Co-Authors Expand Description
Similar People Expand Description
Same Department Expand Description
Physical Neighbors Expand Description